LGT Fund Management Co Ltd. Purchases 12,472 Shares of HCA Healthcare, Inc. $HCA

LGT Fund Management Co Ltd. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 52.1% in the first quarter, HoldingsChannel reports. The firm owned 36,433 shares of the company’s stock after acquiring an additional 12,472 shares during the period. HCA Healthcare makes up 0.7% of LGT Fund Management Co Ltd.’s portfolio, making the stock its 23rd biggest position. LGT Fund Management Co Ltd.’s holdings in HCA Healthcare were worth $17,242,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth about $1,021,000. NewEdge Advisors LLC increased its stake in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC boosted its holdings in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the last quarter. Jump Financial LLC acquired a new position in HCA Healthcare during the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. lifted its holdings in HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after buying an additional 49,214 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA traded down $2.56 during mid-day trading on Friday, hitting $406.45. 1,651,230 shares of the company’s stock were exchanged, compared to its average volume of 1,367,535. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The company has a 50-day simple moving average of $397.56 and a 200 day simple moving average of $460.39. The company has a market cap of $90.17 billion, a PE ratio of 13.98, a P/E/G ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Jefferies Financial Group reaffirmed a “buy” rating and set a $525.00 price objective on shares of HCA Healthcare in a research note on Friday, April 24th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a report on Thursday, June 4th. Barclays downgraded HCA Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $496.00 to $427.00 in a report on Wednesday. Finally, Argus dropped their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $497.14.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.